【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 11
2 Introduction 12
2.1 Spinal Fusion Overview 12
3 Products under Development 13
3.1 Spinal Fusion – Pipeline Products by Stage of Development 13
3.2 Spinal Fusion – Pipeline Products by Segment 14
3.3 Spinal Fusion – Pipeline Products by Territory 15
3.4 Spinal Fusion – Pipeline Products by Regulatory Path 17
3.5 Spinal Fusion – Pipeline Products by Estimated Approval Date 18
3.6 Spinal Fusion – Ongoing Clinical Trials 19
4 Spinal Fusion – Pipeline Products under Development by Companies 20
4.1 Spinal Fusion Companies – Pipeline Products by Stage of Development 20
4.2 Spinal Fusion – Pipeline Products by Stage of Development 22
5 Spinal Fusion Companies and Product Overview 26
5.1 4-Web Spine, LLC Company Overview 26
5.1.1 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.2 Alphatec Holdings, Inc. Company Overview 30
5.2.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 Amedica Corporation Company Overview 41
5.3.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
5.4 APTO Orthopaedics Company Overview 43
5.4.1 APTO Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview 43
5.5 Aurora Spine Corporation Company Overview 44
5.5.1 Aurora Spine Corporation Pipeline Products & Ongoing Clinical Trials Overview 44
5.6 Bio2 Technologies, Inc. Company Overview 49
5.6.1 Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.7 Bonovo Orthopedics, Inc. Company Overview 51
5.7.1 Bonovo Orthopedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.8 Cortical Concepts (Inactive) Company Overview 53
5.8.1 Cortical Concepts (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
5.9 DiFusion Technologies Inc. Company Overview 54
5.9.1 DiFusion Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.10 ECA Medical Instruments, Inc. Company Overview 56
5.10.1 ECA Medical Instruments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 Eden Spine, LLC Company Overview 58
5.11.1 Eden Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.12 Eminent Spine, LLC Company Overview 63
5.12.1 Eminent Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
5.13 Exactech, Inc. Company Overview 66
5.13.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.14 Expanding Orthopedics Inc. Company Overview 68
5.14.1 Expanding Orthopedics Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.15 Globus Medical, Inc. Company Overview 72
5.15.1 Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.16 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 76
5.16.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.17 Implants International Limited Company Overview 77
5.17.1 Implants International Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.18 Integra LifeSciences Holdings Corporation Company Overview 79
5.18.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
5.19 Intelligent Implant Systems, LLC Company Overview 81
5.19.1 Intelligent Implant Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.20 Intrinsic Therapeutics, Inc. Company Overview 83
5.20.1 Intrinsic Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.21 Jemo Spine, LLC. Company Overview 86
5.21.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 86
5.22 Kspine, Inc. Company Overview 87
5.22.1 Kspine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.23 Medtronic plc Company Overview 88
5.23.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 88
5.24 MicroPort Scientific Corporation Company Overview 92
5.24.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 92
5.25 Nasseo, Inc. Company Overview 95
5.25.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.26 NLT SPINE Company Overview 96
5.26.1 NLT SPINE Pipeline Products & Ongoing Clinical Trials Overview 96
5.27 NuVasive, Inc. Company Overview 99
5.27.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.28 OsteoGeneX Inc. Company Overview 104
5.28.1 OsteoGeneX Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.29 OsteoVantage, Inc. Company Overview 107
5.29.1 OsteoVantage, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.30 Paradigm Spine, LLC Company Overview 108
5.30.1 Paradigm Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 108
5.31 Pharmaco-Kinesis Corporation Company Overview 109
5.31.1 Pharmaco-Kinesis Corporation Pipeline Products & Ongoing Clinical Trials Overview 109
5.32 Spinal Balance Inc. Company Overview 110
5.32.1 Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.33 Spinal Simplicity, LLC Company Overview 113
5.33.1 Spinal Simplicity, LLC Pipeline Products & Ongoing Clinical Trials Overview 113
5.34 SpinalVu Inc Company Overview 114
5.34.1 SpinalVu Inc Pipeline Products & Ongoing Clinical Trials Overview 114
5.35 Spine Smith, LP Company Overview 116
5.35.1 Spine Smith, LP Pipeline Products & Ongoing Clinical Trials Overview 116
5.36 Spine Wave, Inc. Company Overview 118
5.36.1 Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118
5.37 SpineAlign Medical, Inc. Company Overview 119
5.37.1 SpineAlign Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119
5.38 SpineCraft, LLC Company Overview 120
5.38.1 SpineCraft, LLC Pipeline Products & Ongoing Clinical Trials Overview 120
5.39 SpineGuard, S.A. Company Overview 122
5.39.1 SpineGuard, S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.40 Spineology Inc. Company Overview 124
5.40.1 Spineology Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.41 Spineway Company Overview 127
5.41.1 Spineway Pipeline Products & Ongoing Clinical Trials Overview 127
5.42 Spinofix Inc Company Overview 129
5.42.1 Spinofix Inc Pipeline Products & Ongoing Clinical Trials Overview 129
5.43 The University of Utah Company Overview 133
5.43.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 133
5.44 University of South Florida Company Overview 134
5.44.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 134
5.45 Vexim SA Company Overview 138
5.45.1 Vexim SA Pipeline Products & Ongoing Clinical Trials Overview 138
5.46 X-spine Systems, Inc. Company Overview 141
5.46.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141
5.47 Zyga Technology, Inc. Company Overview 142
5.47.1 Zyga Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
6 Spinal Fusion – Recent Developments 145
7 Appendix 250
7.1 Methodology 250
7.2 About GlobalData 252
7.3 Contact Us 253
7.4 Disclaimer 253
【レポート販売概要】
■ タイトル:脊椎固定装置の世界市場:パイプラインレビュー2015■ 英文:Spinal Fusion - Pipeline Review, 2015
■ 発行日:2015年4月28日
■ 調査会社:GlobalData
■ 商品コード:GDME0007EPD
■ 調査対象地域:グローバル
- ポイントオブケア(PoC)脂質試験の世界市場分析:機器別(ブランド市場規模:ロシュリフロトロン、ロシュコバス b 101、アバクシスピッコロ、アリーアコレステックLDX、サムスンLABGEO、PTSカーディオチェック)、用途別(高脂血症、高トリグリセリド血症、家族性高コレステロール血症、高リポタンパク血症、タンジール病)、動向分析Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period. Furthermore, c …
- Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 – Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New EntrantsSeasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants Summary GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support …
- 世界におけるデータセンターの物理的セキュリティー市場動向(2014-2018)About Data Center Physical Security Data center physical security is the monitoring of data center hardware and facilities to protect them from external threats and intrusions. Enterprise and data center service providers are adopting various types of equipment and solutions to facilitate efficient monitoring and management of entry into data center facilities. Physical security equipment includes …
- 世界のグリーンパッケージング(持続可能な包装)市場動向(2012-2016)TechNavio's analysts forecast the Global Green (Sustainable) Packaging market to grow at a CAGR of 14.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased environmental concerns. The Global Green (Sustainable) Packaging market has also been witnessing the growing R&D in the Green Packaging sector. However, the capacity reduction and trans …
- 殺虫剤の世界市場:有機リン系殺虫剤、ピレトロイド系殺虫剤、ネオニコチノイド系殺虫剤、メチルカルバメート系殺虫剤About Insecticides Insecticides are a class of pesticides formulated to inhibit or kill the growth of insects on crops and plants. Growing demand for food worldwide has increased the pressure on farmers to enhance their crop yield. Hence, they have begun to adopt insecticides to help meet this demand. The major types of insecticides used include organophosphorous compounds, pyrethroids, neonicotin …
- 自動車用プラスチックの世界市場2015-2022According to Stratistics MRC, the Automotive Plastics Market is expected to reach $48.8 billion by 2022 growing at a CAGR of 14.7% during the forecast period 2015 to 2022. Rapidly growing automobile market, enhancement in vehicle design to reduce weight and emission control and Technological innovations are the key factors fueling the market growth. However, high cost of these materials is one of …
- Bosulif (Chronic Myeloid Leukemia):市場予測と分析(~2022)Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
- Engerix-B(B型肝炎ワクチン)市場動向(~2022)Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related …
- 自動車用高性能サスペンションシステムの世界市場2019-2023114 pages, November 2018 About this market The integration of active steering controls within performance suspension systems will drive growth in the market. Vehicle makers are upgrading their existing vehicular system with digital systems to increase operational efficiency and safety. Technavio’s analysts have predicted that the automotive performance suspension market will register a CAGR of alm …
- 公共安全スペクトラム及びシステム市場動向PPDR usage worldwide is concentrated on a limited number of frequency bands. Among them, the 400 MHz is the most currently used for narrowband systems. At the WRC-15 in November 2015, a decision is to be taken on allocation of frequencies for broadband PPDR spectrum. The 700 MHz is the best candidate at world level, with distinct scenarios being considered. TETRA-like narrowband networks have serv …
- 水性UV硬化樹脂の世界市場予測(~2020)The waterborne UV curable resins market, in terms of value, is projected to reach USD 230.3 Million by 2020, growing at a CAGR of over 13.52% from 2015 to 2020. The key drivers of the waterborne UV curable resins market are environmental concerns, growing awareness, and increasingly stringent regulations for VOC emissions. Dispersions of urethane acrylates (UV-PUDs), often combined with physical d …
- メキシコ/インドネシア/ナイジェリア/トルコの防衛市場:購買/調達動向(~2019)Synopsis This report provides in-depth information on the dynamics of MINT (Mexico, Indonesia, Nigeria and Turkey) defense procurement and trend analysis of imports and exports. The figures are based on trend indicator values (TIV) expressed in US$ million at constant (1990) prices. Although figures are expressed in US$, TIVs do not represent the financial value of goods transferred. Rather, TIVs …
- 世界の量子ドット市場動向(2014-2018)TechNavio’s analysts forecast the Global Quantum Dots market will grow at a CAGR of 69.7 percent over the period 2013-2018. One of the key factors contributing to this market growth is the high performance and cost benefits of quantum dots. The Global Quantum Dots market has also been witnessing the increasing adoption for optoelectronic devices. However, the high cost of quantum dots could pose a …
- エンタープライズ製造インテリジェンス(EMI)の世界市場予測(~ 2022)The enterprise manufacturing intelligence (EMI) market is expected to be valued at USD 3.95 Billion by 2022, growing at a CAGR of 17.1% between 2016 and 2022. The growth of this market is driven by tough competition among the manufacturing companies, growing need for enhanced operational efficiency, rising supplier complexity, and stringent regulatory framework in the highly regulated industries. …
- パウチ包装機械の世界市場2018-2022About this market With the advancement of technologies and rising adoption of automation, various pouch packaging machinery market players are equipping their machines with integrated counters. Benefits including the reduced energy consumption and minimal time required for production are expected to aid the pouch packaging machinery market to register a CAGR of more than 5% by 2022. Market Overvie …